August 4, 2020 — Journal of Ultrasound
Abstract
Lung ultrasound has become an essential tool for rapid bedside assessment in critically unwell patients, proving helpful in assessment of COVID-19 due to logistics of cross-sectional imaging. Contrast enhanced ultrasound (CEUS) further characterizes sonographic features of COVID-19 as multiple areas of infarction, a finding not reproducible on other widely available imaging modalities. CEUS also has the benefit of being cheap, radiation-free, without risk of nephrotoxicity, and can be performed at the bedside. It is predicted that lung CEUS in COVID-19 may help guide prognosis and management. We describe three cases of CEUS in COVID-19.
Authors: Gibran Timothy Yusuf1; Adrian Wong1; Deepak Rao2; Alice Tee1; Cheng Fang1; Paul Singh Sidhu1
1 King’s College Hospital, Denmark Hill, London; 2 Princess Royal University Hospital, Farnborough, Kent, UK
Read full text at: https://doi.org/10.1007/s40477-020-00517-z
